| Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer O Slaby, M Svoboda, P Fabian, T Smerdova, D Knoflickova, ... Oncology 72 (5-6), 397-402, 2008 | 890 | 2008 |
| Identification and functional screening of micro RNA s highly deregulated in colorectal cancer P Faltejskova, M Svoboda, K Srutova, J Mlcochova, A Besse, ... Journal of cellular and molecular medicine 16 (11), 2655-2666, 2012 | 170 | 2012 |
| Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy O Slaby, J Jancovicova, R Lakomy, M Svoboda, A Poprach, P Fabian, ... Journal of Experimental & Clinical Cancer Research 29, 1-7, 2010 | 162 | 2010 |
| Discriminating functional and non‐functional p53 in human tumours by p53 and MDM2 immunohistochemistry R Nenutil, J Smardova, S Pavlova, Z Hanzelkova, P Muller, P Fabian, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2005 | 162 | 2005 |
| MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients M Svoboda, J Sana, P Fabian, I Kocakova, J Gombosova, J Nekvindova, ... Radiation oncology 7, 1-7, 2012 | 151 | 2012 |
| Serum-based microRNA signatures in early diagnosis and prognosis prediction of colon cancer P Vychytilova-Faltejskova, L Radova, M Sachlova, Z Kosarova, K Slaba, ... Carcinogenesis 37 (10), 941-950, 2016 | 146 | 2016 |
| Vnitřní lékařství M Souček, J Špinar, J Vorlíček, Z Adam, D Adámková Krákorová, ... Grada, 2011 | 127 | 2011 |
| Obecná onkologie Z Adam, M Krejčí, J Vorlíček, Z Adamová, J Bačovský, V Bajčiová, ... Galén, 2011 | 97 | 2011 |
| MiR-34b is associated with clinical outcome in triple-negative breast cancer patients M Svoboda, J Sana, M Redova, J Navratil, M Palacova, P Fabian, O Slaby, ... Diagnostic pathology 7, 1-5, 2012 | 91 | 2012 |
| Predicting non-sentinel lymph node status after positive sentinel biopsy in breast cancer: what model performs the best in a Czech population? O Coufal, T Pavlík, P Fabian, R Bori, G Boross, I Sejben, R Maráz, J Koča, ... Pathology & Oncology Research 15, 733-740, 2009 | 75 | 2009 |
| Significant overexpression of Hsp110 gene during colorectal cancer progression O Slaby, K Sobkova, M Svoboda, I Garajova, P Fabian, R Hrstka, ... Oncology reports 21 (5), 1235-1241, 2009 | 73 | 2009 |
| Loss of the p53 tumor suppressor activity is associated with negative prognosis of mantle cell lymphoma L Stefancikova, M Moulis, P Fabian, B Ravcukova, I Vasova, J Muzik, ... International journal of oncology 36 (3), 699-706, 2010 | 64 | 2010 |
| Decreased expression levels of PIWIL1, PIWIL2, and PIWIL4 are associated with worse survival in renal cell carcinoma patients R Iliev, M Stanik, M Fedorko, A Poprach, P Vychytilova-Faltejskova, ... OncoTargets and therapy, 217-222, 2016 | 55 | 2016 |
| Prognostic impact of p53 aberrations for R-CHOP-treated patients with diffuse large B-cell lymphoma L Stefancikova, M Moulis, P Fabian, I Vasova, F Zedek, B Ravcukova, ... International journal of oncology 39 (6), 1413-1420, 2011 | 52 | 2011 |
| Epithelial-mesenchymal transition-associated microRNA/mRNA signature is linked to metastasis and prognosis in clear-cell renal cell carcinoma H Mlcochova, T Machackova, A Rabien, L Radova, P Fabian, R Iliev, ... Scientific reports 6 (1), 31852, 2016 | 43 | 2016 |
| RAS mutation prevalence among patients with metastatic colorectal cancer: a meta-analysis of real-world data G Kafatos, D Niepel, K Lowe, S Jenkins-Anderson, H Westhead, ... Biomarkers in medicine 11 (9), 751-760, 2017 | 42 | 2017 |
| Triple negative breast cancer J Navratil, P Fabian, M Palacova, K Petrakova, R Vyzula, M Svoboda Klinicka onkologie: casopis Ceske a Slovenske onkologicke spolecnosti 28 (6 …, 2015 | 41 | 2015 |
| AGR2 predicts tamoxifen resistance in postmenopausal breast cancer patients R Hrstka, V Brychtova, P Fabian, B Vojtesek, M Svoboda Disease markers 35 (4), 207-212, 2013 | 41 | 2013 |
| HLA-G and HLA-E specific mRNAs connote opposite prognostic significance in renal cell carcinoma L Kren, I Valkovsky, J Dolezel, I Capak, D Pacik, A Poprach, R Lakomy, ... Diagnostic Pathology 7, 1-7, 2012 | 41 | 2012 |
| Hepatocellular carcinoma: gene expression profiling and regulation of xenobiotic-metabolizing cytochromes P450 J Nekvindova, A Mrkvicova, V Zubanova, AH Vaculova, P Anzenbacher, ... Biochemical pharmacology 177, 113912, 2020 | 35 | 2020 |
